Precidian ETFs Trust - Novo Nordisk A/S (B Shares) ADRhedged Long Term Debt

As of the most recent data (September 2016), NVOH shows a long-term debt of $2.3B. That compares with $560M in the prior-year period — up 314.2% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, NVOH's long-term debt is now $2.3B (was $560M) — a 314.2% year-over-year increase. Pairing that YoY change with peer averages gives a clearer picture of whether Precidian ETFs Trust - Novo Nordisk A/S (B Shares) ADRhedged is outperforming or lagging.

Tracking NVOH's long-term debt over time shows whether Precidian ETFs Trust - Novo Nordisk A/S (B Shares) ADRhedged is scaling, shrinking, or reshaping that part of the business. The current reading is $2.3B That compares with $560M in the prior-year period — up 314.2% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this long-term debt page, Stockcircle has Precidian ETFs Trust - Novo Nordisk A/S (B Shares) ADRhedged's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect long-term debt (currently $2.3B) with ownership activity and broader fundamentals.